STAAR Surgical (STAA) Competitors

STAAR Surgical (NASDAQ:STAA) and National Vision (NASDAQ:EYE) are both mid-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, risk, earnings, community ranking and institutional ownership.

Which has more volatility and risk, STAA or EYE?

STAAR Surgical has a beta of 1.18, indicating that its share price is 18% more volatile than the S&P 500. Comparatively, National Vision has a beta of 1.4, indicating that its share price is 40% more volatile than the S&P 500.

Does the media refer more to STAA or EYE?

In the previous week, National Vision had 2 more articles in the media than STAAR Surgical. MarketBeat recorded 6 mentions for National Vision and 4 mentions for STAAR Surgical. STAAR Surgical's average media sentiment score of 1.09 beat National Vision's score of 0.33 indicating that STAAR Surgical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
STAAR Surgical	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
National Vision	2 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Is STAA or EYE more profitable?

STAAR Surgical has a net margin of 10.81% compared to National Vision's net margin of 1.48%. STAAR Surgical's return on equity of 9.85% beat National Vision's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
STAAR Surgical	10.81%	9.85%	7.93%
National Vision	1.48%	3.99%	1.56%

Do analysts prefer STAA or EYE?

STAAR Surgical currently has a consensus target price of $81.18, suggesting a potential upside of 40.70%. National Vision has a consensus target price of $30.33, suggesting a potential upside of 16.80%. Given STAAR Surgical's stronger consensus rating and higher possible upside, analysts plainly believe STAAR Surgical is more favorable than National Vision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
STAAR Surgical	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
National Vision	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

Do institutionals and insiders believe in STAA or EYE?

97.6% of STAAR Surgical shares are owned by institutional investors. 1.1% of STAAR Surgical shares are owned by insiders. Comparatively, 2.1% of National Vision shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Does the MarketBeat Community believe in STAA or EYE?

STAAR Surgical received 22 more outperform votes than National Vision when rated by MarketBeat users. However, 67.65% of users gave National Vision an outperform vote while only 58.64% of users gave STAAR Surgical an outperform vote.

Company	Underperform	Outperform
STAAR Surgical	Outperform Votes 275 58.64%	Underperform Votes 194 41.36%
National Vision	Outperform Votes 253 67.65%	Underperform Votes 121 32.35%

Which has stronger valuation and earnings, STAA or EYE?

National Vision has higher revenue and earnings than STAAR Surgical. National Vision is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
STAAR Surgical	$284.39 million	9.81	$38.76 million	$0.64	90.16
National Vision	$2.01 billion	1.01	$42.12 million	$0.37	70.19

Summary

STAAR Surgical beats National Vision on 12 of the 18 factors compared between the two stocks.